Greykasell Wealth Strategies’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.11M Sell
3,142
-4
-0.1% -$1.43K 0.45% 52
2025
Q4
$1.03M Buy
3,146
+7
+0.2% +$2.22K 0.41% 62
2025
Q3
$886K Buy
3,139
+171
+6% +$49.6K 0.37% 66
2025
Q2
$829K Buy
2,968
+91
+3% +$25.8K 0.4% 64
2025
Q1
$896K Buy
2,877
+1
+0% +$295 0.48% 59
2024
Q4
$750K Buy
+2,876
New +$853K 0.42% 68

Other funds holding AMGN

Greykasell Wealth Strategies's AMGN Position: Q1 2026 in Review

Greykasell Wealth Strategies reduced its Amgen (AMGN) stake by 0.13% in Q1 2026, selling an estimated $1.43K and leaving 3,142 shares worth $1.11M. The position accounts for 0.45% of the portfolio, ranked #52.

Greykasell Wealth Strategies first reported a position in AMGN in Q4 2024 and has held it in 6 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Greykasell Wealth Strategies held 3,142 shares of Amgen worth $1.11M as of Q1 2026.
  • Greykasell Wealth Strategies sold 4 Amgen shares in Q1 2026, an estimated $1.43K.
  • Amgen made up 0.45% of Greykasell Wealth Strategies's portfolio in Q1 2026, its #52 holding.
  • Greykasell Wealth Strategies first reported a position in Amgen in Q4 2024 and has held it in 6 quarters since.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Greykasell Wealth Strategies's 13F filing for Q1 2026, filed 7 May 2026.